Across TCGA pan-cancer cohorts, LINC01670 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC01670’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where LINC01670 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01670 is over-expressed in tumor.
LUSC and LIHC are the cancer types where LINC01670 tumor–normal differential expression is most reproducible.